Skip to main content
SpringerLink
Log in

Anxiety Comorbidities: Mood Disorders, Substance Use Disorders, and Chronic Medical Illness

  • Chapter
  • First Online:
Clinical Handbook of Anxiety Disorders

Part of the book series: Current Clinical Psychiatry ((CCPSY))

Abstract

Anxiety disorders are highly prevalent and are associated with significant negative consequences. Importantly, a large proportion of individuals with anxiety disorders also meet criteria for other disorders. Specifically, a large body of work suggests that anxiety is often comorbid with mood and substance use disorders, as well as physical health conditions, including chronic pain. These comorbidities contribute to overall disease burden and are associated with greater overall severity of each disorder compared to individuals with only one disorder, and these individuals also exhibit poor treatment outcomes. Therefore, there is clinical utility in understanding the relationships between anxiety and its comorbidities. The following chapter reviews existing research examining the relationship between anxiety and mood disorders, substance use disorders, and chronic pain. Each section provides a comprehensive review of existing research on the etiology and treatment of these comorbidities, as well as provides a framework for future directions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington: American Psychiatric Association; 2013.

    Book  Google Scholar 

  2. Remes O, Brayne C, van der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 2016;6(7):e00497. https://doi.org/10.1002/brb3.497.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(8):807–16. https://doi.org/10.1001/archpsyc.61.8.807.

    Article  PubMed  Google Scholar 

  4. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264(19):2511–8. https://doi.org/10.1001/jama.1990.03450190043026.

    Article  CAS  PubMed  Google Scholar 

  5. Wittchen H-U, Kessler RC, Beesdo K, Krause P, Höfler M, Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63(Suppl 8):24–34.

    PubMed  Google Scholar 

  6. Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1–13. https://doi.org/10.1016/j.drugalcdep.2015.05.031.

    Article  PubMed  Google Scholar 

  7. DeJean D, Giacomini M, Vanstone M, Brundisini F. Patient experiences of depression and anxiety with chronic disease. Ont Health Technol Assess Ser. 2013;13(16):1–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144(3):766–77. https://doi.org/10.1378/chest.12-1911.

    Article  PubMed  Google Scholar 

  9. Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev. 2000;20(2):149–71. https://doi.org/10.1016/S0272-7358(99)00027-6.

    Article  CAS  PubMed  Google Scholar 

  10. Myrick H, Brady K. Current review of the comorbidity of affective, anxiety, and substance use disorders. Curr Opin Psychiatry. 2003;16(3):261. https://doi.org/10.1097/01.yco.0000069080.26384.d8.

    Article  Google Scholar 

  11. Coplan JD, Aaronson CJ, Panthangi V, Kim Y. Treating comorbid anxiety and depression: psychosocial and pharmacological approaches. World J Psychiatry. 2015;5(4):366–78. https://doi.org/10.5498/wjp.v5.i4.366.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(4):415–24. https://doi.org/10.1001/archpsyc.63.4.415.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.

    Article  CAS  Google Scholar 

  14. Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008;29:115–29. https://doi.org/10.1146/annurev.publhealth.29.020907.090847.

    Article  PubMed  Google Scholar 

  15. Goodwin RD, Roy-Byrne P. Panic and suicidal ideation and suicide attempts: results from the National Comorbidity Survey. Depress Anxiety. 2006;23(3):124–32. https://doi.org/10.1002/da.20151.

    Article  PubMed  Google Scholar 

  16. Goodwin R, Hamilton SP. Cigarette smoking and panic: the role of neuroticism. Am J Psychiatr. 2002;159(7):1208–13. https://doi.org/10.1176/appi.ajp.159.7.1208.

    Article  PubMed  Google Scholar 

  17. Stein MB, Fuetsch M, Müller N, Höfler M, Lieb R, Wittchen HU. Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults. Arch Gen Psychiatry. 2001;58(3):251–6.

    Article  CAS  Google Scholar 

  18. Wittchen H-U. Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety. 2002;16(4):162–71. https://doi.org/10.1002/da.10065.

    Article  PubMed  Google Scholar 

  19. Batelaan NM, Rhebergen D, Spinhoven P, van Balkom AJ, Penninx BWJH. Two-year course trajectories of anxiety disorders: do DSM classifications matter? J Clin Psychiatry. 2014;75(9):985–93. https://doi.org/10.4088/JCP.13m08837.

    Article  PubMed  Google Scholar 

  20. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry. 1996;53(2):159–68.

    Article  CAS  Google Scholar 

  21. Newman MG, Przeworski A, Fisher AJ, Borkovec TD. Diagnostic comorbidity in adults with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses. Behav Ther. 2010;41(1):59–72. https://doi.org/10.1016/j.beth.2008.12.005.

    Article  PubMed  Google Scholar 

  22. Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol. 1998;107(2):179–92.

    Article  CAS  Google Scholar 

  23. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder: same genes, (partly) different environments? Arch Gen Psychiatry. 1992b;49(9):716–22. https://doi.org/10.1001/archpsyc.1992.01820090044008.

    Article  CAS  PubMed  Google Scholar 

  24. Demirkan A, Penninx BWJH, Hek K, Wray NR, Amin N, Aulchenko YS, van Dyck R, de Geus EJC, Hofman A, Uitterlinden AG, Hottenga J-J, Nolen WA, Oostra BA, Sullivan PF, Willemsen G, Zitman FG, Tiemeier H, Janssens ACJW, Boomsma DI, van Duijn CM, Middeldorp CM. Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry. 2011;16(7):773–83. https://doi.org/10.1038/mp.2010.65.

    Article  CAS  PubMed  Google Scholar 

  25. Hettema JM. The nosologic relationship between generalized anxiety disorder and major depression. Depress Anxiety. 2008;25(4):300–16. https://doi.org/10.1002/da.20491.

    Article  PubMed  Google Scholar 

  26. Kendler KS, Aggen SH, Neale MC. Evidence for multiple genetic factors underlying DSM-IV criteria for major depression. JAMA Psychiat. 2013;70(6):599–607. https://doi.org/10.1001/jamapsychiatry.2013.751.

    Article  CAS  Google Scholar 

  27. Smoller JW. The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology. 2016;41(1):297–319. https://doi.org/10.1038/npp.2015.266.

    Article  CAS  PubMed  Google Scholar 

  28. Micco JA, Henin A, Mick E, Kim S, Hopkins CA, Biederman J, Hirshfeld-Becker DR. Anxiety and depressive disorders in offspring at high risk for anxiety: a meta-analysis. J Anxiety Disord. 2009;23(8):1158–64. https://doi.org/10.1016/j.janxdis.2009.07.021.

    Article  PubMed  Google Scholar 

  29. Smoller JW. Disorders and borders: psychiatric genetics and nosology. Am J Med Genet B Neuropsychiatr Genet. 2013;162B(7):559–78. https://doi.org/10.1002/ajmg.b.32174.

    Article  CAS  PubMed  Google Scholar 

  30. Donner J, Sipilä T, Ripatti S, Kananen L, Chen X, Kendler KS, et al. Support for involvement of glutamate decarboxylase 1 and neuropeptide Y in anxiety susceptibility. Am J Med Genet B Neuropsychiatr Genet. 2012;159B:316–27.

    Article  Google Scholar 

  31. Hettema JM, An SS, Neale MC, Bukszar J, van den Oord EJCG, Kendler KS, et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry. 2006;11:752.

    Article  CAS  Google Scholar 

  32. Smolka MN, Schumann G, Wrase J, Grüsser SM, Flor H, Mann K, et al. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci. 2005;25:836–42.

    Article  CAS  Google Scholar 

  33. Domschke K, Dannlowski U. Imaging genetics of anxiety disorders. NeuroImage. 2010;53:822–31.

    Article  CAS  Google Scholar 

  34. Bastiaansen JA, Servaas MN, Marsman JBC, Ormel J, Nolte IM, Riese H, Aleman A. Filling the gap: relationship between the serotonin-transporter-linked polymorphic region and amygdala activation. Psychol Sci. 2014;25(11):2058–66. https://doi.org/10.1177/0956797614548877.

    Article  PubMed  Google Scholar 

  35. Howe AS, Buttenschøn HN, Bani-Fatemi A, Maron E, Otowa T, Erhardt A, Binder EB, Gregersen NO, Mors O, Woldbye DP, Domschke K, Reif A, Shlik J, Kõks S, Kawamura Y, Miyashita A, Kuwano R, Tokunaga K, Tanii H, Smoller JW, Sasaki T, Koszycki D, De Luca V. Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways. Mol Psychiatry. 2016;21(5):665–79. https://doi.org/10.1038/mp.2015.138.

    Article  CAS  PubMed  Google Scholar 

  36. Munafò MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry. 2008;63(9):852–7. https://doi.org/10.1016/j.biopsych.2007.08.016.

    Article  CAS  PubMed  Google Scholar 

  37. McLeod BD, Weisz JR, Wood JJ. Examining the association between parenting and childhood depression: a meta-analysis. Clin Psychol Rev. 2007;27(8):986–1003. https://doi.org/10.1016/j.cpr.2007.03.001.

    Article  PubMed  Google Scholar 

  38. Lovejoy MC, Graczyk PA, O’Hare E, Neuman G. Maternal depression and parenting behavior: a meta-analytic review. Clin Psychol Rev. 2000;20(5):561–92.

    Article  CAS  Google Scholar 

  39. Davila J, Ramsay M, Stroud CB, Steinberg SJ. Attachment as vulnerability to the development of psychopathology. In: Development of psychopathology: a vulnerability-stress perspective; 2005. p. 215–42. https://doi.org/10.4135/9781452231655.

    Chapter  Google Scholar 

  40. Spinhoven P, Elzinga BM, Hovens JGFM, Roelofs K, Zitman FG, van Oppen P, Penninx BWJH. The specificity of childhood adversities and negative life events across the life span to anxiety and depressive disorders. J Affect Disord. 2010;126(1–2):103–12. https://doi.org/10.1016/j.jad.2010.02.132.

    Article  PubMed  Google Scholar 

  41. Huh HJ, Kim KH, Lee H-K, Chae J-H. The relationship between childhood trauma and the severity of adulthood depression and anxiety symptoms in a clinical sample: the mediating role of cognitive emotion regulation strategies. J Affect Disord. 2017;213:44–50. https://doi.org/10.1016/j.jad.2017.02.009.

    Article  PubMed  Google Scholar 

  42. Heim C, Nemeroff CB. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry. 2001;49(12):1023–39.

    Article  CAS  Google Scholar 

  43. Penza KM, Heim C, Nemeroff CB. Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety. Arch Womens Ment Health. 2003;6(1):15–22. https://doi.org/10.1007/s00737-002-0159-x.

    Article  CAS  PubMed  Google Scholar 

  44. Shonkoff JP, Boyce WT, McEwen BS. Neuroscience, molecular biology, and the childhood roots of health disparities: building a new framework for health promotion and disease prevention. JAMA. 2009;301(21):2252–9. https://doi.org/10.1001/jama.2009.754.

    Article  CAS  PubMed  Google Scholar 

  45. Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci. 2007;10(9):1116–24. https://doi.org/10.1038/nn1944.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Beesdo K, Lau JYF, Guyer AE, McClure-Tone EB, Monk CS, Nelson EE, Fromm SJ, Goldwin MA, Wittchen HU, Leibenluft E, Ernst M, Pine DS. Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. Arch Gen Psychiatry. 2009;66(3):275–85. https://doi.org/10.1001/archgenpsychiatry.2008.545.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164(10):1476–88. https://doi.org/10.1176/appi.ajp.2007.07030504.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Frodl TS, Koutsouleris N, Bottlender R, Born C, Jäger M, Scupin I, et al. Depression-related variation in brain morphology over 3 years: effects of stress? Arch Gen Psychiatry. 2008;65(10):1156–65.

    Article  Google Scholar 

  49. Godlewska BR, Norbury R, Selvaraj S, Cowen PJ, Harmer CJ. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med. 2012;42(12):2609–17. https://doi.org/10.1017/S0033291712000591.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Messina I, Sambin M, Palmieri A, Viviani R. Neural correlates of psychotherapy in anxiety and depression: a meta-analysis. PLoS One. 2013;8(9):e74657. https://doi.org/10.1371/journal.pone.0074657.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Fales CL, Barch DM, Rundle MM, Mintun MA, Snyder AZ, Cohen JD, Mathews J, Sheline YI. Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biol Psychiatry. 2008;63(4):377–84. https://doi.org/10.1016/j.biopsych.2007.06.012.

    Article  PubMed  Google Scholar 

  52. Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HMC, Chen G, McClure-Tone EB, Ernst M, Pine DS. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry. 2008;65(5):568–76. https://doi.org/10.1001/archpsyc.65.5.568.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Bocchio-Chiavetto L, Bagnardi V, Zanardini R, Molteni R, Nielsen MG, Placentino A, Giovannini C, Rillosi L, Ventriglia M, Riva MA, Gennarelli M. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry. 2010;11(6):763–73. https://doi.org/10.3109/15622971003611319.

    Article  PubMed  Google Scholar 

  54. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008;11(8):1169–80. https://doi.org/10.1017/S1461145708009309.

    Article  CAS  PubMed  Google Scholar 

  55. Molendijk ML, Bus BA, Spinhoven P, Penninx BWJH, Kenis G, Prickaerts J, Voshaar RC, Elzinga BM. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry. 2011;16(11):1088–95. https://doi.org/10.1038/mp.2010.98.

    Article  CAS  PubMed  Google Scholar 

  56. Enns MW, Cox BJ. Personality dimensions and depression: review and commentary. Can J Psychol. Revue Canadienne De Psychiatrie. 1997;42(3):274–84. https://doi.org/10.1177/070674379704200305.

    Article  CAS  Google Scholar 

  57. Hettema JM, Prescott CA, Kendler KS. Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Am J Psychiatry. 2004;161(9):1581–7. https://doi.org/10.1176/appi.ajp.161.9.1581.

    Article  PubMed  Google Scholar 

  58. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry. 2002;159(7):1133–45. https://doi.org/10.1176/appi.ajp.159.7.1133.

    Article  PubMed  Google Scholar 

  59. Aldinger M, Stopsack M, Ulrich I, Appel K, Reinelt E, Wolff S, Grabe HJ, Lang S, Barnow S. Neuroticism developmental courses – implications for depression, anxiety and everyday emotional experience; a prospective study from adolescence to young adulthood. BMC Psychiatry. 2014;14:210. https://doi.org/10.1186/s12888-014-0210-2.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Weinstock LM, Whisman MA. Neuroticism as a common feature of the depressive and anxiety disorders: a test of the revised integrative hierarchical model in a national sample. J Abnorm Psychol. 2006;115(1):68–74. https://doi.org/10.1037/0021-843X.115.1.68.

    Article  PubMed  Google Scholar 

  61. Zinbarg RE, Mineka S, Bobova L, Craske MG, Vrshek-Schallhorn S, Griffith JW, Wolitzky-Taylor K, Waters AM, Sumner JA, Anand D. Testing a hierarchical model of neuroticism and its cognitive facets: latent structure and prospective prediction of first onsets of anxiety and unipolar mood disorders during 3 years in late adolescence. Clin Psychol Sci. 2016;4(5):805–24. https://doi.org/10.1177/2167702615618162.

    Article  Google Scholar 

  62. Reiss S, McNally RJ. Expectancy model of fear. In: Reiss S, Bootzin R, editors. Theoretical issues in behavior therapy. San Diego: Academic; 1985. p. 107–21.

    Google Scholar 

  63. Rector NA, Szacun-Shimizu K, Leybman M. Anxiety sensitivity within the anxiety disorders: disorder-specific sensitivities and depression comorbidity. Behav Res Ther. 2007;45(8):1967–75. https://doi.org/10.1016/j.brat.2006.09.017.

    Article  PubMed  Google Scholar 

  64. Allan NP, Capron DW, Raines AM, Schmidt NB. Unique relations among anxiety sensitivity factors and anxiety, depression, and suicidal ideation. J Anxiety Disord. 2014a;28(2):266–75. https://doi.org/10.1016/j.janxdis.2013.12.004.

    Article  PubMed  Google Scholar 

  65. Allan NP, Macatee RJ, Norr AM, Schmidt NB. Direct and interactive effects of distress tolerance and anxiety sensitivity on generalized anxiety and depression. Cogn Ther Res. 2014b;38(5):530–40. https://doi.org/10.1007/s10608-014-9623-y.

    Article  Google Scholar 

  66. Johnson SL, Turner RJ, Iwata N. BIS/BAS levels and psychiatric disorder: an epidemiological study. J Psychopathol Behav Assess. 2003;25(1):25–36. https://doi.org/10.1023/A:1022247919288.

    Article  Google Scholar 

  67. Nigg JT. Temperament and developmental psychopathology. J Child Psychol Psychiatry. 2006;47(3–4):395–422. https://doi.org/10.1111/j.1469-7610.2006.01612.x.

    Article  PubMed  Google Scholar 

  68. Chronis-Tuscano A, Degnan KA, Pine DS, Perez-Edgar K, Henderson HA, Diaz Y, Raggi VL, Fox NA. Stable early maternal report of behavioral inhibition predicts lifetime social anxiety disorder in adolescence. J Am Acad Child Adolesc Psychiatry. 2009;48(9):928–35. https://doi.org/10.1097/CHI.0b013e3181ae09df.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Rosenbaum JF, Biederman J, Hirshfeld-Becker DR, Kagan J, Snidman N, Friedman D, Nineberg A, Gallery DJ, Faraone SV. A controlled study of behavioral inhibition in children of parents with panic disorder and depression. Am J Psychiatry. 2000;157(12):2002–10. https://doi.org/10.1176/appi.ajp.157.12.2002.

    Article  CAS  PubMed  Google Scholar 

  70. Gentes EL, Ruscio AM. A meta-analysis of the relation of intolerance of uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and obsessive-compulsive disorder. Clin Psychol Rev. 2011;31(6):923–33. https://doi.org/10.1016/j.cpr.2011.05.001.

    Article  PubMed  Google Scholar 

  71. Kotov R, Gamez W, Schmidt F, Watson D. Linking “big” personality traits to anxiety, depressive, and substance use disorders: a meta-analysis. Psychol Bull. 2010;136(5):768–821. https://doi.org/10.1037/a0020327.

    Article  PubMed  Google Scholar 

  72. Britton JC, Lissek S, Grillon C, Norcross MA, Pine DS. Development of anxiety: the role of threat appraisal and fear learning. Depress Anxiety. 2011;28(1):5–17. https://doi.org/10.1002/da.20733.

    Article  PubMed  Google Scholar 

  73. Bittner A, Goodwin RD, Wittchen H-U, Beesdo K, Höfler M, Lieb R. What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry. 2004;65(5):618–26, quiz 730.

    Article  Google Scholar 

  74. Garber J, Weersing VR. Comorbidity of anxiety and depression in youth: implications for treatment and prevention. Clin Psychol. 2010;17(4):293–306. https://doi.org/10.1111/j.1468-2850.2010.01221.x.

    Article  Google Scholar 

  75. Starr LR, Davila J. Responding to anxiety with rumination and hopelessness: mechanism of anxiety-depression symptom co-occurrence? Cogn Ther Res. 2012;36(4):321–37. https://doi.org/10.1007/s10608-011-9363-1.

    Article  Google Scholar 

  76. Conklin LR, Cassiello-Robbins C, Brake CA, Sauer-Zavala S, Farchione TJ, Ciraulo DA, Barlow DH. Relationships among adaptive and maladaptive emotion regulation strategies and psychopathology during the treatment of comorbid anxiety and alcohol use disorders. Behav Res Ther. 2015;73:124–30. https://doi.org/10.1016/j.brat.2015.08.001.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(3):752–62. https://doi.org/10.1097/MIB.0000000000000620.

    Article  PubMed  Google Scholar 

  78. Baldwin DS. Serotonin noradrenaline reuptake inhibitors: a new generation of treatment for anxiety disorders. Int J Psychiatry Clin Pract. 2006;10(Suppl 2):12–5. https://doi.org/10.1080/13651500600637056.

    Article  CAS  PubMed  Google Scholar 

  79. Simon NM, Rosenbaum JF. Anxiety and depression comorbidity: implications and intervention. 2003. Retrieved from http://www.medscape.com/viewarticle/451325_print

  80. Wuthrich VM, Rapee RM. Randomised controlled trial of group cognitive behavioural therapy for comorbid anxiety and depression in older adults. Behav Res Ther. 2013;51(12):779–86. https://doi.org/10.1016/j.brat.2013.09.002.

    Article  PubMed  Google Scholar 

  81. Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders. Behav Ther. 2004;35(2):205–30. https://doi.org/10.1016/S0005-7894(04)80036-4.

    Article  Google Scholar 

  82. Barlow DH, Farchione TJ, Bullis JR, Gallagher MW, Murray-Latin H, Sauer-Zavala S, Bentley KH, Thompson-Hollands J, Conklin LR, Boswell JF, Ametaj A, Carl JR, Boettcher HT, Cassiello-Robbins C. The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders: a randomized clinical trial. JAMA Psychiat. 2017;74(9):875–84. https://doi.org/10.1001/jamapsychiatry.2017.2164.

    Article  Google Scholar 

  83. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits: a meta-analysis. J Psychosom Res. 2004;57(1):35–43. https://doi.org/10.1016/S0022-3999(03)00573-7.

    Article  PubMed  Google Scholar 

  84. A-Tjak JGL, Davis ML, Morina N, Powers MB, Smits JAJ, Emmelkamp PMG. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom. 2015;84(1):30–6. https://doi.org/10.1159/000365764.

    Article  PubMed  Google Scholar 

  85. Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA, Brutsché NE, Ameli R, Furey ML, Zarate CA. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res. 2014;58:161–6. https://doi.org/10.1016/j.jpsychires.2014.07.027.

    Article  PubMed  Google Scholar 

  86. Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, Axmacher N, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry. 2010;67(2):110–6. https://doi.org/10.1016/j.biopsych.2009.09.013.

    Article  PubMed  Google Scholar 

  87. Schiffer F, Johnston AL, Ravichandran C, Polcari A, Teicher MH, Webb RH, Hamblin MR. Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct. 2009;5(1):46. https://doi.org/10.1186/1744-9081-5-46.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Amir N, Beard C, Cobb M, Bomyea J. Attention modification program in individuals with generalized anxiety disorder. J Abnorm Psychol. 2009;118(1):28–33. https://doi.org/10.1037/a0012589.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Hakamata Y, Lissek S, Bar-Haim Y, Britton JC, Fox N, Leibenluft E, Ernst M, Pine DS. Attention Bias modification treatment: a meta-analysis towards the establishment of novel treatment for anxiety. Biol Psychiatry. 2010;68(11):982–90. https://doi.org/10.1016/j.biopsych.2010.07.021.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Rapee RM, MacLeod C, Carpenter L, Gaston JE, Frei J, Peters L, Baillie AJ. Integrating cognitive bias modification into a standard cognitive behavioural treatment package for social phobia: a randomized controlled trial. Behav Res Ther. 2013;51(4):207–15. https://doi.org/10.1016/j.brat.2013.01.005.

    Article  PubMed  Google Scholar 

  91. Lazarov A, Suarez-Jimenez B, Tamman A, Falzon L, Zhu X, Edmondson DE, Neria Y. Attention to threat in posttraumatic stress disorder as indexed by eye-tracking indices: a systematic review. Psychol Med. 2018:1–22. https://doi.org/10.1017/S0033291718002313.

    Article  Google Scholar 

  92. Hardin MG, Schroth E, Pine DS, Ernst M. Incentive-related modulation of cognitive control in healthy, anxious, and depressed adolescents: development and psychopathology related differences. J Child Psychol Psychiatry. 2007;48(5):446–54. https://doi.org/10.1111/j.1469-7610.2006.01722.x.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Siegle GJ, Ghinassi F, Thase ME. Neurobehavioral therapies in the 21st century: summary of an emerging field and an extended example of cognitive control training for depression. Cogn Ther Res. 2007;31(2):235–62. https://doi.org/10.1007/s10608-006-9118-6.

    Article  Google Scholar 

  94. Sanislow CA, Pine DS, Quinn KJ, Kozak MJ, Garvey MA, Heinssen RK, et al. Developing constructs for psychopathology research: research domain criteria. J Abnorm Psychol. 2010;119(4):631.

    Article  Google Scholar 

  95. Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J Abnorm Psychol. 2005;114(4):522.

    Article  Google Scholar 

  96. Insel TR. The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry. Am J Psychiatr. 2014;171(4):395–7.

    Article  Google Scholar 

  97. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11(1):126.

    Article  Google Scholar 

  98. Calkins AW, McMorran KE, Siegle GJ, Otto MW. The effects of computerized cognitive control training on community adults with depressed mood. Behav Cogn Psychother. 2015;43(5):578–89.

    Article  Google Scholar 

  99. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, Bijl R, Borges G, Caraveo-Anduaga JJ, DJ DW, Kolody B, Vega WA, Wittchen HU, Kessler RC. Comorbidity of substance use disorders with mood and anxiety disorders: results of the international consortium in psychiatric epidemiology. Addict Behav. 1998;23(6):893–907. https://doi.org/10.1016/S0306-4603(98)00076-8.

    Article  CAS  PubMed  Google Scholar 

  100. Robinson J, Sareen J, Cox BJ, Bolton JM. Role of self-medication in the development of comorbid anxiety and substance use disorders: a longitudinal investigation. Arch Gen Psychiatry. 2011;68(8):800–7. https://doi.org/10.1001/archgenpsychiatry.2011.75.

    Article  PubMed  Google Scholar 

  101. de Graaf R, Bijl RV, ten Have M, Beekman ATF, Vollebergh WAM. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study. J Affect Disord. 2004;82(3):461–7. https://doi.org/10.1016/j.jad.2004.03.001.

    Article  PubMed  Google Scholar 

  102. de Graaf R, Bijl RV, Spijker J, Beekman ATF, Vollebergh WAM. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders. Soc Psychiatry Psychiatr Epidemiol. 2003;38(1):1–11. https://doi.org/10.1007/s00127-003-0597-4.

    Article  PubMed  Google Scholar 

  103. Howland RH, John Rush A, Wisniewski SR, Trivedi MH, Warden D, Fava M, Davis LL, Balasubramani GK, PJ MG, Berman SR. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend. 2009;99(1):248–60. https://doi.org/10.1016/j.drugalcdep.2008.08.010.

    Article  PubMed  Google Scholar 

  104. Buckner JD, Heimberg RG, Ecker AH, Vinci C. A biopsychosocial model of social anxiety and substance use. Depress Anxiety. 2013;30(3):276–84. https://doi.org/10.1002/da.22032.

    Article  PubMed  Google Scholar 

  105. Cox BJ, Ron Norton G, Swinson RP, Endler NS. Substance abuse and panic-related anxiety: a critical review. Behav Res Ther. 1990;28(5):385–93. https://doi.org/10.1016/0005-7967(90)90157-E.

    Article  CAS  PubMed  Google Scholar 

  106. Magidson JF, Liu S-M, Lejuez CW, Blanco C. Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample. J Psychiatr Res. 2012;46(5):659–66. https://doi.org/10.1016/j.jpsychires.2012.02.011.

    Article  PubMed  PubMed Central  Google Scholar 

  107. McHugh RK. Treatment of co-occurring anxiety disorders and substance use disorders. Harv Rev Psychiatry. 2015;23(2):99–111. https://doi.org/10.1097/HRP.0000000000000058.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005;162(6):1179–87. https://doi.org/10.1176/appi.ajp.162.6.1179.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman ATF, Penninx BWJH. Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry J Ment Sci. 2012;200(6):476–84. https://doi.org/10.1192/bjp.bp.111.097550.

    Article  Google Scholar 

  110. Cooper ML, Frone MR, Russell M, Mudar P. Drinking to regulate positive and negative emotions: a motivational model of alcohol use. J Pers Soc Psychol. 1995;69(5):990–1005.

    Article  CAS  Google Scholar 

  111. Wolitzky-Taylor K, Bobova L, Zinbarg RE, Mineka S, Craske MG. Longitudinal investigation of the impact of anxiety and mood disorders in adolescence on subsequent substance use disorder onset and vice versa. Addict Behav. 2012;37(8):982–5. https://doi.org/10.1016/j.addbeh.2012.03.026.

    Article  PubMed  PubMed Central  Google Scholar 

  112. de Graaf R, Bijl RV, Smit F, Vollebergh WAM, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands mental health survey and incidence study. Am J Psychiatr. 2002;159(4):620–9. https://doi.org/10.1176/appi.ajp.159.4.620.

    Article  PubMed  Google Scholar 

  113. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60(9):929–37. https://doi.org/10.1001/archpsyc.60.9.929.

    Article  PubMed  Google Scholar 

  114. Compton WM 3rd, Cottler LB, Ben Abdallah A, Phelps DL, Spitznagel EL, Horton JC. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am J Addict. 2000;9(2):113–25.

    Article  Google Scholar 

  115. Kendler KS, Davis CG, Kessler RC. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br J Psychiatry. 1997;170(6):541–8. https://doi.org/10.1192/bjp.170.6.541.

    Article  CAS  PubMed  Google Scholar 

  116. Nicholls J, Staiger PK, Williams JS, Richardson B, Kambouropoulos N. When social anxiety co-occurs with substance use: does an impulsive social anxiety subtype explain this unexpected relationship? Psychiatry Res. 2014;220(3):909–14. https://doi.org/10.1016/j.psychres.2014.08.040.

    Article  PubMed  Google Scholar 

  117. Jakuszkowiak-Wojten K, Landowski J, Wiglusz MS, Cubała WJ. Impulsivity in anxiety disorders. A critical review. Psychiatr Danub. 2015;27(Suppl 1):S452–5.

    PubMed  Google Scholar 

  118. Perry JL, Carroll ME. The role of impulsive behavior in drug abuse. Psychopharmacology. 2008;200(1):1–26. https://doi.org/10.1007/s00213-008-1173-0.

    Article  CAS  PubMed  Google Scholar 

  119. Bevilacqua L, Goldman D. Genetics of impulsive behaviour. Philos Trans R Soc B. 2013;368(1615). https://doi.org/10.1098/rstb.2012.0380.

    Article  Google Scholar 

  120. Anokhin AP, Grant JD, Mulligan RC, Heath AC. The genetics of impulsivity: evidence for the heritability of delay discounting. Biol Psychiatry. 2015;77(10):887–94. https://doi.org/10.1016/j.biopsych.2014.10.022.

    Article  PubMed  Google Scholar 

  121. Kendler KS, Bulik CM, Silberg J, Hettema JM, Myers J, Prescott CA. Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and Cotwin control analysis. Arch Gen Psychiatry. 2000a;57(10):953–9. https://doi.org/10.1001/archpsyc.57.10.953.

    Article  CAS  PubMed  Google Scholar 

  122. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Childhood parental loss and adult psychopathology in women: a twin study perspective. Arch Gen Psychiatry. 1992a;49(2):109–16. https://doi.org/10.1001/archpsyc.1992.01820020029004.

    Article  CAS  PubMed  Google Scholar 

  123. Kendler KS, Myers J, Prescott CA. Parenting and adult mood, anxiety and substance use disorders in female twins: an epidemiological, multi-informant, retrospective study. Psychol Med. 2000b;30(2):281–94.

    Article  CAS  Google Scholar 

  124. Cattell RB. The meaning and measurement of neuroticism and anxiety: supplement to a review. Br J Soc Clin Psychol. 1963;2(3):224–6. https://doi.org/10.1111/j.2044-8260.1963.tb00394.x.

    Article  Google Scholar 

  125. Brown RA, Kahler CW, Zvolensky MJ, Lejuez CW, Ramsey SE. Anxiety sensitivity: relationship to negative affect smoking and smoking cessation in smokers with past major depressive disorder. Addict Behav. 2001;26(6):887–99. https://doi.org/10.1016/S0306-4603(01)00241-6.

    Article  CAS  PubMed  Google Scholar 

  126. Leventhal AM, Zvolensky MJ. Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity. Psychol Bull. 2015;141(1):176–212. https://doi.org/10.1037/bul0000003.

    Article  PubMed  Google Scholar 

  127. Zvolensky MJ, Marshall EC, Johnson K, Hogan J, Bernstein A, Bonn-Miller MO. Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity marijuana use motives among young adult marijuana users. Exp Clin Psychopharmacol. 2009;17(1):31–42. https://doi.org/10.1037/a0014961.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Simons JS, Gaher RM. The distress tolerance scale: development and validation of a self-report measure. Motiv Emot. 2005;29(2):83–102. https://doi.org/10.1007/s11031-005-7955-3.

    Article  Google Scholar 

  129. Leyro TM, Zvolensky MJ, Bernstein A. Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults. Psychol Bull. 2010;136(4):576–600. https://doi.org/10.1037/a0019712.

    Article  PubMed  PubMed Central  Google Scholar 

  130. Daughters SB, Reynolds EK, MacPherson L, Kahler CW, Danielson CK, Zvolensky M, Lejuez CW. Distress tolerance and early adolescent externalizing and internalizing symptoms: the moderating role of gender and ethnicity. Behav Res Ther. 2009;47(3):198–205. https://doi.org/10.1016/j.brat.2008.12.001.

    Article  PubMed  Google Scholar 

  131. Watkins KE, Hunter SB, Burnam MA, Pincus HA, Nicholson G. Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatr Serv. 2005;56(8):913–26. https://doi.org/10.1176/appi.ps.56.8.913.

    Article  PubMed  Google Scholar 

  132. Brady KT, Verduin ML. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders. Subst Use Misuse. 2005;40(13–14):2021–41. https://doi.org/10.1080/10826080500294924.

    Article  PubMed  Google Scholar 

  133. Danion JM, Neunreuther C, Krieger-Finance F, Imbs JL, Singer L. Compliance with long-term lithium treatment in major affective disorders. Pharmacopsychiatry. 1987;20(5):230–1. https://doi.org/10.1055/s-2007-1017111.

    Article  CAS  PubMed  Google Scholar 

  134. Schadé A, Marquenie LA, van Balkom AJLM, Koeter MWJ, de Beurs E, van Dyck R, van den Brink W. Anxiety disorders: treatable regardless of the severity of comorbid alcohol dependence. Eur Addict Res. 2007;13(2):109–15. https://doi.org/10.1159/000097941.

    Article  PubMed  Google Scholar 

  135. Kushner MG, Maurer EW, Thuras P, Donahue C, Frye B, Menary KR, Hobbs J, Haeny AM, Van Demark J. Hybrid cognitive behavioral therapy versus relaxation training for co-occurring anxiety and alcohol disorder: a randomized clinical trial. J Consult Clin Psychol. 2013;81(3):429–42. https://doi.org/10.1037/a0031301.

    Article  PubMed  Google Scholar 

  136. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJG, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30(3):208–25. https://doi.org/10.1016/j.genhosppsych.2007.12.006.

    Article  Google Scholar 

  137. Sareen J, Cox BJ, Stein MB, Afifi TO, Fleet C, Asmundson GJG. Physical and mental comorbidity, disability, and suicidal behavior associated with posttraumatic stress disorder in a large community sample. Psychosom Med. 2007;69(3):242–8. https://doi.org/10.1097/PSY.0b013e31803146d8.

    Article  PubMed  Google Scholar 

  138. Asmundson GJG, Katz J. Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety. 2009;26(10):888–901. https://doi.org/10.1002/da.20600.

    Article  PubMed  Google Scholar 

  139. Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015;16(8):769–80. https://doi.org/10.1016/j.jpain.2015.05.002.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Fishbain DA, Goldberg M, Meagher BR, Steele R, Rosomoff H. Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain. 1986;26(2):181–97.

    Article  CAS  Google Scholar 

  141. Large RG. DSM-III diagnoses in chronic pain. Confusion or clarity? J Nerv Ment Dis. 1986;174(5):295–303.

    Article  CAS  Google Scholar 

  142. Reich J, Tupin JP, Abramowitz SI. Psychiatric diagnosis of chronic pain patients. Am J Psychiatry. 1983;140(11):1495–8. https://doi.org/10.1176/ajp.140.11.1495.

    Article  CAS  PubMed  Google Scholar 

  143. Atkinson JH, Slater MA, Patterson TL, Grant I, Garfin SR. Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: a controlled study. Pain. 1991;45(2):111–21.

    Article  CAS  Google Scholar 

  144. Kinney RK, Gatchel RJ, Polatin PB, Fogarty WT, Mayer TG. Prevalence of psychopathology in acute and chronic low back pain patients. J Occup Rehabil. 1993;3(2):95–103. https://doi.org/10.1007/BF01078162.

    Article  CAS  PubMed  Google Scholar 

  145. Polatin PB, Kinney RK, Gatchel RJ, Lillo E, Mayer TG. Psychiatric illness and chronic low-back pain. The mind and the spine – which goes first? Spine. 1993;18(1):66–71.

    Article  CAS  Google Scholar 

  146. Asmundson GJG, Taylor S. Role of anxiety sensitivity in pain-related fear and avoidance. J Behav Med. 1996;19(6):577–86. https://doi.org/10.1007/BF01904905.

    Article  CAS  PubMed  Google Scholar 

  147. Krishnan KRR, France RD, Pelton S, McCann UD, Davidson J, Urban BJ. Chronic pain and depression. II. Symptoms of anxiety in chronic low back pain patients and their relationship to subtypes of depression. Pain. 1985;22(3):289–94. https://doi.org/10.1016/0304-3959(85)90029-6.

    Article  CAS  PubMed  Google Scholar 

  148. Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med. 2008;70(8):890–7. https://doi.org/10.1097/PSY.0b013e318185c510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  149. McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106(1):127–33. https://doi.org/10.1016/S0304-3959(03)00301-4.

    Article  PubMed  Google Scholar 

  150. McCracken LM, Gross RT. Does anxiety affect coping with chronic pain? Clin J Pain. 1993;9(4):253–9.

    Article  CAS  Google Scholar 

  151. Teh CF, Morone NE, Karp JE, Belnap BH, Zhu F, Weiner DK, Rollman BL. Pain interference impacts response to treatment for anxiety disorders. Depress Anxiety. 2009;26(3):222–8. https://doi.org/10.1002/da.20514.

    Article  PubMed  PubMed Central  Google Scholar 

  152. McCracken LM, Dhingra L. A short version of the pain anxiety symptoms scale (PASS-20): preliminary development and validity. Pain Res Manag. 2002;7(1):45–50.

    Article  Google Scholar 

  153. Rogers AH, Bakhshaie J, Lam H, Langdon KJ, Ditre JW, Zvolensky MJ. Pain-related anxiety and opioid misuse in a racially/ethnically diverse young adult sample with moderate/severe pain. Cogn Behav Ther. 2018:1–11. https://doi.org/10.1080/16506073.2018.1436085.

    Article  Google Scholar 

  154. LaRowe LR, Langdon KJ, Zvolensky MJ, Zale EL, Ditre JW. Pain-related anxiety as a predictor of early lapse and relapse to cigarette smoking. Exp Clin Psychopharmacol. 2017;25(4):255–64. https://doi.org/10.1037/pha0000127.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  155. Kindt M, Soeter M, Vervliet B. Beyond extinction: erasing human fear responses and preventing the return of fear. Nat Neurosci. 2009;12(3):256–8. https://doi.org/10.1038/nn.2271.

    Article  CAS  PubMed  Google Scholar 

  156. Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B, Tepper S. Efficacy of gabapentin in migraine prophylaxis. Headache. 2001;41(2):119–28.

    Article  CAS  Google Scholar 

  157. Urquhart DM, Hoving JL, Assendelft WWJJ, Roland M, van Tulder MW. Antidepressants for non-specific low back pain. Cochrane Database Syst Rev. 2008;(1):CD001703. https://doi.org/10.1002/14651858.CD001703.pub3.

  158. Morley S, Eccleston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain. 1999;80(1):1–13. https://doi.org/10.1016/S0304-3959(98)00255-3.

    Article  CAS  PubMed  Google Scholar 

  159. Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012;11:CD007407. https://doi.org/10.1002/14651858.CD007407.pub3.

    Article  PubMed  Google Scholar 

  160. Veehof MM, Oskam M-J, Schreurs KMG, Bohlmeijer ET. Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis. Pain. 2011;152(3):533–42. https://doi.org/10.1016/j.pain.2010.11.002.

    Article  PubMed  Google Scholar 

  161. Wetherell JL, Afari N, Rutledge T, Sorrell JT, Stoddard JA, Petkus AJ, Solomon BC, Lehman DH, Liu L, Lang AJ, Hampton Atkinson J. A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain. 2011;152(9):2098–107. https://doi.org/10.1016/j.pain.2011.05.016.

    Article  PubMed  Google Scholar 

  162. Vlaeyen JW, de Jong J, Sieben J, Crombez G. Graded exposure in vivo for pain-related fear. In: Turk DC, Gatchel RJ, editors. Psychological approaches to pain management: a practioner’s handbook. 2nd ed. New York: Guilford Press; 2002. p. 210–33.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, University of Houston, Houston, TX, USA

    Andrew H. Rogers

  2. Department of Psychology, Suffolk University, Boston, MA, USA

    Sarah T. Wieman

  3. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA

    Amanda W. Baker

  4. Department of Psychiatry, Harvard University, Boston, MA, USA

    Amanda W. Baker

Authors
  1. Andrew H. Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah T. Wieman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amanda W. Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah T. Wieman .

Editor information

Editors and Affiliations

  1. Department of Psychiatry Massachusetts General Hospital, Boston, MA, USA

    Eric Bui

  2. Department of Psychiatry Massachusetts General Hospital, Boston, MA, USA

    Meredith E. Charney

  3. Department of Psychiatry Massachusetts General Hospital, Boston, MA, USA

    Amanda W. Baker

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rogers, A.H., Wieman, S.T., Baker, A.W. (2020). Anxiety Comorbidities: Mood Disorders, Substance Use Disorders, and Chronic Medical Illness. In: Bui, E., Charney, M., Baker, A. (eds) Clinical Handbook of Anxiety Disorders. Current Clinical Psychiatry. Humana, Cham. https://doi.org/10.1007/978-3-030-30687-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-30687-8_5

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-30686-1

  • Online ISBN: 978-3-030-30687-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation